A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2
Clinical trial NCT03580278 · COMPLETED
Trial details
- NCT number
- NCT03580278
- Sponsor
- Affibody
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2020-09-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.